India Tightens Ebola Surveillance at Airports, Issues Travel Advisory for African Nations

IMT News Desk
IMT News Desk
· 2 min read
India tightens Ebola surveillance at airports and issues a travel advisory for passengers from affected African nations amid outbreak concerns

India has tightened Ebola surveillance at airports and other points of entry after the World Health Organization declared the outbreak in parts of Africa a Public Health Emergency of International Concern (PHEIC), while health authorities issued a fresh advisory for travellers from affected countries.

The Directorate General of Health Services, under the Union health ministry, has asked passengers arriving from or transiting through the Democratic Republic of Congo, Uganda and South Sudan to immediately report to airport health officers if they develop symptoms such as fever, vomiting, diarrhoea, weakness, headache, sore throat, muscle pain or unexplained bleeding.

The advisory, issued by the Airport Health Organisation, also directs travellers who had direct contact with the blood or body fluids of a suspected or confirmed Ebola patient to report to airport health desks before immigration clearance. Passengers who develop symptoms within 21 days of arrival have been told to seek immediate medical care and inform healthcare authorities about their travel history.

Health officials said no Ebola case has been reported in India so far, but surveillance and preparedness measures are being strengthened as a precautionary step. Earlier reports said the ministry had reviewed screening, quarantine, laboratory preparedness and isolation arrangements at major airports and ports, with the National Institute of Virology in Pune identified for testing support.

Ebola is a severe viral disease that spreads through direct contact with infected bodily fluids and contaminated surfaces, not through the air. The latest move reflects India’s effort to prevent importation of the infection while keeping passengers and frontline health workers alert to symptoms and exposure risks.

The fresh advisory comes as global health agencies continue to monitor outbreaks in Africa, where suspected and confirmed cases have been reported in the Democratic Republic of Congo and Uganda. Indian authorities said the country’s public health system remains on alert and that preparedness measures will continue to be intensified at airports, seaports and land borders.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk